Correlation Between Cipher Pharmaceuticals and Wilmington Capital

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cipher Pharmaceuticals and Wilmington Capital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cipher Pharmaceuticals and Wilmington Capital into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cipher Pharmaceuticals and Wilmington Capital Management, you can compare the effects of market volatilities on Cipher Pharmaceuticals and Wilmington Capital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cipher Pharmaceuticals with a short position of Wilmington Capital. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cipher Pharmaceuticals and Wilmington Capital.

Diversification Opportunities for Cipher Pharmaceuticals and Wilmington Capital

-0.19
  Correlation Coefficient

Good diversification

The 3 months correlation between Cipher and Wilmington is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Cipher Pharmaceuticals and Wilmington Capital Management in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Wilmington Capital and Cipher Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cipher Pharmaceuticals are associated (or correlated) with Wilmington Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Wilmington Capital has no effect on the direction of Cipher Pharmaceuticals i.e., Cipher Pharmaceuticals and Wilmington Capital go up and down completely randomly.

Pair Corralation between Cipher Pharmaceuticals and Wilmington Capital

Assuming the 90 days trading horizon Cipher Pharmaceuticals is expected to under-perform the Wilmington Capital. In addition to that, Cipher Pharmaceuticals is 1.63 times more volatile than Wilmington Capital Management. It trades about -0.08 of its total potential returns per unit of risk. Wilmington Capital Management is currently generating about -0.04 per unit of volatility. If you would invest  250.00  in Wilmington Capital Management on September 6, 2025 and sell it today you would lose (10.00) from holding Wilmington Capital Management or give up 4.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy98.44%
ValuesDaily Returns

Cipher Pharmaceuticals  vs.  Wilmington Capital Management

 Performance 
       Timeline  
Cipher Pharmaceuticals 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Cipher Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's technical indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
Wilmington Capital 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Wilmington Capital Management has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Wilmington Capital is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Cipher Pharmaceuticals and Wilmington Capital Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cipher Pharmaceuticals and Wilmington Capital

The main advantage of trading using opposite Cipher Pharmaceuticals and Wilmington Capital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cipher Pharmaceuticals position performs unexpectedly, Wilmington Capital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Wilmington Capital will offset losses from the drop in Wilmington Capital's long position.
The idea behind Cipher Pharmaceuticals and Wilmington Capital Management pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume